International Journal of Radiation Oncology*Biology*Physics
Arm lymphedema in patients treated conservatively for breast cancer: Relationship to patient age and axillary node dissection technique
References (23)
- et al.
The effect of adjuvant chemotherapy on the cosmetic results after primary radiation treatment for early stage breast cancer
Int. J. Radiat. Oncol. Biol. Phys.
(1984) - et al.
The effect of adjuvant chemotherapy on cosmesis and complications in patients with breast cancer treated by definitive irradiation
Int. J. Radiat. Oncol. Biol. Phys.
(1983) A study of the pathogenesis of postmastectomy lymphedema
Tohoku J. Exp. Med.
(1976)- et al.
The role of lymphovenous communication in the development of postmastectomy lymph-edema
Surgery
(1984) - et al.
Cosmetic results following primary radiation therapy for early breast cancer
Cancer
(1984) - et al.
Patterns of axillary nodal involvement in breast cancer: predictability of level one dissection
Ann. Surg.
(1982) - et al.
Postoperative lymphedema after treatment of breast cancer
Acta Chir. Scand.
(1983) - et al.
Causes and treatment of postmastectomy lymphedema of the arm
J.A.M.A.
(1962) - et al.
Postmastectomy lymphedema
S.G.O.
(1965)
Complete axillary lymph node dissection before radiotherapy for primary breast cancer
Cited by (141)
Skin dose-volume predictors of moderate-severe late side effects after whole breast radiotherapy
2024, Radiotherapy and OncologyManagement of Melanoma Patients with Positive Nodes
2020, Advances in SurgeryCitation Excerpt :There are no data to support partial lymph node dissection in patients with palpable or bulky lymphadenopathy; however, the necessity of radical axillary dissection of level III lymph nodes recently has been questioned. Removal of these nodes in breast cancer patients has been shown with longer operative time, increased blood loss, and increased risk of lymphedema; however, these data have not been recapitulated in melanoma patients [12,13]. In several retrospective analyses, level III lymph nodes were found positive at rates between 17% and 30% in patients with clinically palpable nodes preoperatively [14–16].
Lymphedema in the postmastectomy patient: Pathophysiology, prevention, and management
2018, The Breast: Comprehensive Management of Benign and Malignant DiseasesA model to estimate the risk of breast cancer-related lymphedema: Combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy
2013, International Journal of Radiation Oncology Biology PhysicsCitation Excerpt :Among patient-related factors, age and BMI were investigated. In the literature, increased age (>60 years) and obesity have been reported to be important risk factors for LE (10, 11). We found no correlation between those factors and LE, possibly because BMIs of our patients were mostly in the normal range or <25 kg/m2 (67%).
Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy
2012, International Journal of Radiation Oncology Biology PhysicsCitation Excerpt :Although recent technical advances have reduced the risk of post-RT complications, irradiation of the chest wall and regional lymphatics should still be reserved for patient subgroups for whom it has been shown to be consistently beneficial. Supraclavicular lymph node irradiation has been historically linked to an increased risk of arm edema (22–24), brachial plexopathy (25–27), pneumonitis (28–30), and esthetic sequelae (31–33). Meric et al. (33), in a series of 294 prospectively monitored patients undergoing breast RT in 1991 and 1992, found that about 1 in 10 patients developed Grade 2 or greater complications, such as arm edema, breast skin fibrosis, and limited arm motion after breast-conserving surgery with or without axillary lymph node dissection.